Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways

• Main Authors: Kent Miner (Author), Katja Labitzke (Author), Benxian Liu (Author), Paul Wang (Author), Kathryn Henckels (Author), Kevin Gaida (Author), Robin Elliott (Author), Jian Jeffrey Chen (Author), Longbin Liu (Author), Anh Leith (Author), Esther Trueblood (Author), Kelly Hensley (Author), Xing-Zhong Xia (Author), Oliver Homann (Author), Brian Bennett (Author), Mike Fiorino (Author), John Whoriskey (Author), Gang Yu (Author), Sabine Escobar (Author), Min Wong (Author), Teresa L. Born (Author), Alison Budelsky (Author), Mike Comeau (Author), Dirk Smith (Author), Jonathan Phillips (Author), James A. Johnston (Author), Joseph G. McGivern (Author), Kerstin Weikl (Author), David Powers (Author), Karl Kunzelmann (Author), Deanna Mohn (Author), Andreas Hochheimer (Author), John K. Sullivan (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

There is an unmet need in severe asthma where approximately 40% of patients exhibit poor β-agonist responsiveness, suffer daily symptoms and show frequent exacerbations. Antagonists of the Ca2+-activated Cl− channel, TMEM16A, offers a new mechanism to bronchodilate airways and block the multiple con...